During the previous funding period, we established an Nkx2.8-null mouse, in which the gene was replaced by a LacZ reporter gene under control of the intact Nkx2.8 promoter. In large airways of adult mice, reporter gene expression was confined to a subset of basal cells, and the number of expressing cells was significantly expanded in the Nkx2.8-/- mouse compared to Nkx2.8 heterozygotes. This cell expansion led to wide- spread bronchial dysplasia and aged mice had a high incidence of lung cancer. In development, Nkx2.8-expressing cells appeared relatively late, after the lungs had formed. First apparent in the distal lung buds, the cells spread upward throughout the bronchi and trachea, and eventually formed separate cell populations in the tracheo- bronchial and bronchioloalveolar regions. Both populations show properties of local stem cells. However, the null mutation deregulates only the tracheobronchial population. Increased LacZ-positive cells were associated with bronchial hyperplasia from birth, and labeling studies demonstrated that increased proliferation persisted in adults. Nkx2.8 therefore appears to act as a negative regulator that limits the number of tracheobron- chial stem cells. We propose new studies to accelerate the development of spontaneous bronchial cancer (Aim 1). The experiments will test the role of genetic background and suppressor-gene mutations on bronchial tumor progression. Other studies (Aim 2) will exploit the marker gene to analyze the dynamics of stem cell maintenance and differentiation, and their perturbation by the null-mutation. Histopathology and flow cytometry will correlate proliferation and differentiation markers in LacZ-expressing cells, which will also be isolated to characterize expression profiles, and differentiation properties in primary cell culture.
Aim 3 will analyze tumor suppressive properties of induced Nkx2.8 expression in human lung cancer cells. Expression profiles from these cells will be com- pared to those obtained from mouse bronchial cell fractions, to determine specific relationships between tumor and stem cell regulation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA076354-10
Application #
7891197
Study Section
Cancer Molecular Pathobiology Study Section (CAMP)
Program Officer
Mietz, Judy
Project Start
1998-07-01
Project End
2012-07-31
Budget Start
2010-08-01
Budget End
2012-07-31
Support Year
10
Fiscal Year
2010
Total Cost
$264,921
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Pathology
Type
Schools of Medicine
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Locker, Joseph; Segall, Jeffrey E (2011) Breast cancer: the matrix is the message. Am J Pathol 178:966-8
Harris, Thomas; Pan, Qiulu; Sironi, Juan et al. (2011) Both gene amplification and allelic loss occur at 14q13.3 in lung cancer. Clin Cancer Res 17:690-9
Kajiyama, Yasuo; Tian, Jianmin; Locker, Joseph (2006) Characterization of distant enhancers and promoters in the albumin-alpha-fetoprotein locus during active and silenced expression. J Biol Chem 281:30122-31
Tian, Jianmin; Mahmood, Radma; Hnasko, Robert et al. (2006) Loss of Nkx2.8 deregulates progenitor cells in the large airways and leads to dysplasia. Cancer Res 66:10399-407
Pirity, Melinda K; Locker, Joseph; Schreiber-Agus, Nicole (2005) Rybp/DEDAF is required for early postimplantation and for central nervous system development. Mol Cell Biol 25:7193-202
Columbano, Amedeo; Ledda-Columbano, Giovanna M; Pibiri, Monica et al. (2005) Gadd45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia. Hepatology 42:1118-26
Locker, Joseph; Tian, Jianmin; Carver, Robert et al. (2003) A common set of immediate-early response genes in liver regeneration and hyperplasia. Hepatology 38:314-25
Kajiyama, Yasuo; Tian, Jianmin; Locker, Joseph (2002) Regulation of alpha-fetoprotein expression by Nkx2.8. Mol Cell Biol 22:6122-30
Locker, Joseph; Ghosh, David; Luc, Phuong-Van et al. (2002) Definition and prediction of the full range of transcription factor binding sites--the hepatocyte nuclear factor 1 dimeric site. Nucleic Acids Res 30:3809-17
Vorachek, W R; Steppan, C M; Lima, M et al. (2000) Distant enhancers stimulate the albumin promoter through complex proximal binding sites. J Biol Chem 275:29031-41